SCHEMBL2485807

SCHEMBL2485807

CC(C)(C)OC(=O)N1CCCC1C(=O)Nc1nc(-c2ccccc2)c(-c2ccccc2)o1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 2/20 0.54
NPC1 O15118 1/20 0.52
KMT2A Q03164 4/20 0.52
MEN1 O00255 3/20 0.52
LMNA P02545 3/20 0.51
NPSR1 Q6W5P4 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.50
KDM4E B2RXH2 5/20 0.49
ALDH1A1 P00352 2/20 0.49
NR4A2 P43354 1/20 0.49
JAK2 O60674 1/20 0.47
POLB P06746 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
UCHL1 P09936 1/20 0.45
HPGD P15428 2/20 0.44
HTT P42858 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2485805 1.00 USP30 (0.54) USP30NPC1KMT2AMEN1LMNA
SCHEMBL2486141 0.87 LMNA (0.52) USP30KMT2AMEN1LMNAKDM4E
SCHEMBL1752680 0.79 NPC1 (0.74) USP30NPC1KMT2AMEN1LMNA
SCHEMBL17765418 0.79 NPC1 (0.74) USP30NPC1KMT2AMEN1LMNA
SCHEMBL2389717 0.78 NPC1 (0.77) USP30NPC1KMT2AMEN1LMNA
SCHEMBL2525285 0.78 NPC1 (0.77) USP30NPC1KMT2AMEN1LMNA
SCHEMBL12765472 0.78 USP30 (0.55) USP30NPC1KMT2AMEN1LMNA
SCHEMBL2317236 0.77 L3MBTL1 (0.56) USP30NPC1KMT2AMEN1LMNA
SCHEMBL20370279 0.77 USP30 (0.70) USP30NPC1KMT2AMEN1LMNA
SCHEMBL2490286 0.77 L3MBTL1 (0.56) USP30NPC1KMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2559455-A1 Heteroaryl derivatives as DGAT1 inhibitors Novartis AG (CH) 2013-02-20 EP disclosed
EP-2548618-A2 Organic compounds Novartis AG (CH) 2013-01-23 EP disclosed
EP-2380631-A1 Heteroaryl derivatives as DGAT1 inhibitors Novartis AG (CH) 2011-10-26 EP disclosed